Xebra Brands
Source: Xebra Brands.
  • Xebra Brands (XBRA) has announced a $600,000 private placement and a share consolidation
  • The consolidation will occur on February 28, 2023, on the basis of 1 post-consolidation share for each 5 pre-consolidation shares
  • The non-brokered financing will consist of up to 8,000,000 units priced, on a post-consolidated basis, at $0.075 each
  • Xebra Brands is an international cannabis cultivation and consumer product company
  • Xebra Brands (XBRA) opened with a gain of 25 per cent trading at $0.025 per share

Xebra Brands (XBRA) has announced a $600,000 private placement and a share consolidation.

The consolidation will occur on February 28, 2023, on the basis of 1 post-consolidation share for each 5 pre-consolidation shares. Any fraction of a common share will be rounded up or down to the nearest whole number.

As a result of the consolidation, Xebra’s outstanding common shares will be reduced to 39,339,581, on a pre-offering basis.

The non-brokered financing will consist of up to 8,000,000 units priced, on a post-consolidated basis, at $0.075 each.

Each unit is comprised of one common share and one common share purchase warrant.

Each warrant entitles the holder to acquire one common share for $0.10 for up to 18 months following the closing of the financing.

The company expects the financing to close on or about March 1, 2023.

All securities issued are subject to a hold period of four months and one day.

Xebra Brands is an international cannabis cultivation and consumer product company.

Xebra Brands (XBRA) opened with a gain of 25 per cent trading at $0.025 per share.


More From The Market Online
Cannabis Report across cannabis plants

StockTalk | Cannabis Report: Shake-ups

MediPharm Labs announced that chief executive officer, David Pidduck will step down from his role, effective January...

Buzz on the Bullboards: As Arctic tensions flare, investors eye three news‑making stocks

Global markets opened the week on edge as a fresh rift between Washington and key NATO...

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition.
Cannabis leaves with Stock Talk and Cannabis Report labels

StockTalk | Cannabis Report: New digs

Cannabis e-commerce company Herbal Dispatch (CSE:HERB) grew sales by 38 per cent in 2025, marking its third-straight year...